Abstract
Four preterm newborn infants with severe multisystem Coxsackie virus B infection were treated with an oral suspension of pleconaril (5 mg/kg per day). The patients had myocarditis, fulminant hepatitis, meningoencephalitis and disseminated intravascular coagulopathy. All four infants recovered, and no adverse effects of the treatment were noted. Conclusion: pleconaril needs to be comprehensively evaluated in this population.
| Original language | English |
|---|---|
| Pages (from-to) | 491-493 |
| Number of pages | 3 |
| Journal | European Journal of Pediatrics |
| Volume | 161 |
| Issue number | 9 |
| DOIs | |
| State | Published - 2002 |
| Externally published | Yes |
Keywords
- Coxsackie virus
- Enterovirus
- Neonate
- Pleconaril